compound 9 (Chembridge)
Structured Review
![<t>Compound</t> <t>9</t> chemical structure and binding to human SERCA2a using FRET. ( A ) Chemical structure of Compound 9. ( B ) Fluorescence lifetime (FLT) response of the human SERCA2a mCyRFP1-mMaroon FRET biosensor to a range of [Compound 9]. Samples were obtained from a stable HEK293 cell line expressing the FRET biosensor. Null controls containing the corresponding volume of DMSO were read at the same time. Data are represented as means ± SD ( n = 3). ∗ p < 0.05 versus control, using unpaired, two-way Student’s t -test.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_0338/pmc12860338/pmc12860338__gr1.jpg)
Compound 9, supplied by Chembridge, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound+9/pmc12860338-56-0-5?v=Chembridge
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "A piperidinyl amide compound enhances Ca 2+ signaling in cardiomyocytes by increasing activity of Ca 2+ pump"
Article Title: A piperidinyl amide compound enhances Ca 2+ signaling in cardiomyocytes by increasing activity of Ca 2+ pump
Journal: Biophysical Reports
doi: 10.1016/j.bpr.2026.100250
Figure Legend Snippet: Compound 9 chemical structure and binding to human SERCA2a using FRET. ( A ) Chemical structure of Compound 9. ( B ) Fluorescence lifetime (FLT) response of the human SERCA2a mCyRFP1-mMaroon FRET biosensor to a range of [Compound 9]. Samples were obtained from a stable HEK293 cell line expressing the FRET biosensor. Null controls containing the corresponding volume of DMSO were read at the same time. Data are represented as means ± SD ( n = 3). ∗ p < 0.05 versus control, using unpaired, two-way Student’s t -test.
Techniques Used: Binding Assay, Fluorescence, Expressing, Control
Figure Legend Snippet: Effect of Compound 9 on Ca 2+ signaling in mouse ventricular myocytes. ( A ) F/F 0 profiles of cytosolic Ca 2+ during AP-induced and caffeine-induced Ca 2+ transients (i.e., SR Ca 2+ load) in control conditions and in the presence of Compound 9 (10 μM). The recordings were made from wild-type (WT) ventricular myocytes. ( B ) The average effects of Compound 9 ( n = 12 myocytes) on AP-induced Ca 2+ transient amplitude, SR Ca 2+ load LTCC-induced Ca 2+ transient amplitude, and the fractional release (FR). ∗ p < 0.05 versus control.
Techniques Used: Control
Figure Legend Snippet: Effect of Compound 9 on Ca 2+ signaling during adrenergic receptor activation. ( A ) F/F 0 profiles of cytosolic Ca 2+ during AP-induced and caffeine-induced Ca 2+ transients (i.e., SR Ca 2+ load) in control conditions, in the presence of ISO (0.1 μM) with following application of Compound 9 (10 μM). The recordings were made from WT ventricular myocytes. ( B ) The average effects of ISO (0.1 μM) and ISO + Compound 9 ( n = 10 myocytes) on AP-induced Ca 2+ transient amplitude, SR Ca 2+ load LTCC-induced Ca 2+ transient amplitude, and the fractional release (FR). ∗ p < 0.05 versus ISO alone.
Techniques Used: Activation Assay, Control
Figure Legend Snippet: Effect of Compound 9 on Ca 2+ signaling in cardiomyocytes isolated from PLB knockout mice. ( A ) F/F 0 profiles of cytosolic Ca 2+ during AP-induced and caffeine-induced Ca 2+ transients (i.e., SR Ca 2+ load) in control conditions and in the presence of Compound 9 (10 μM). The recordings were made from PLB knockout ventricular myocytes. ( B ) The average effects of Compound 9 ( n = 13 myocytes) on AP-induced Ca 2+ transient amplitude, SR Ca 2+ load LTCC-induced Ca 2+ transient amplitude, and the fractional release (FR). ∗ p < 0.05 versus control.
Techniques Used: Isolation, Knock-Out, Control
